• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥沙利铂和 5-氟尿嘧啶经肝动脉灌注联合静脉西妥昔单抗治疗不可切除的直肠癌肝转移获得持久缓解。

Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.

机构信息

Department of Surgical Oncology, Oncologisch Centrum UZ Brussel, Brussels, Belgium.

出版信息

Curr Oncol. 2011 Oct;18(5):e256-9. doi: 10.3747/co.v18i5.789.

DOI:10.3747/co.v18i5.789
PMID:21980258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3185908/
Abstract

At diagnosis of a cT3N0M1 adenocarcinoma of the rectum with synchronous inoperable liver metastases, a 59-year-old man was treated with preoperative radiotherapy (5×5 Gy), followed by laparoscopy-assisted anterior resection of the rectum with total mesorectal excision. At the first postoperative evaluation, a new lung metastasis was detected. First-line chemotherapy with folfiri (5-fluorouracil, irinotecan, leucovorin) resulted in transient stabilization of the metastatic liver disease. At progression, oxaliplatin and 5-fluorouracil-folinic acid were administered by intrahepatic arterial infusion, in combination with intravenous cetuximab. A partial radiologic response was obtained, with complete metabolic response on fluorodeoxyglucose positron-emission tomography, and normalization of carcinoembryonic antigen values. The solitary lung metastasis was sequentially treated with radiotherapy and resection. Five years after the initial diagnosis, this patient remains free from progression, with residual cystic remnants of the liver metastases visible on conventional computed tomography imaging, but not enhancing with fluorodeoxyglucose positron-emission tomography.

摘要

一位 59 岁男性被诊断为直肠 cT3N0M1 腺癌,合并同步不可切除的肝转移。该患者接受了术前放疗(5×5 Gy),随后行腹腔镜辅助直肠前切除术和全直肠系膜切除术。在首次术后评估时,发现新的肺转移。患者接受一线化疗方案 folfiri(5-氟尿嘧啶、伊立替康、亚叶酸)治疗,转移性肝疾病暂时稳定。疾病进展时,采用奥沙利铂和氟尿嘧啶-亚叶酸经肝动脉输注联合静脉西妥昔单抗治疗。获得部分影像学缓解,氟脱氧葡萄糖正电子发射断层扫描显示完全代谢缓解,癌胚抗原值正常化。孤立性肺转移瘤随后接受放疗和切除术治疗。在初始诊断后的 5 年,该患者无疾病进展,常规计算机断层扫描显示肝转移的囊性残留,但氟脱氧葡萄糖正电子发射断层扫描无增强。

相似文献

1
Durable remission of inoperable liver metastasis from rectal cancer after hepatic arterial infusion of oxaliplatin and 5-fluorouracil in combination with intravenous cetuximab.奥沙利铂和 5-氟尿嘧啶经肝动脉灌注联合静脉西妥昔单抗治疗不可切除的直肠癌肝转移获得持久缓解。
Curr Oncol. 2011 Oct;18(5):e256-9. doi: 10.3747/co.v18i5.789.
2
A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases.一例初始不可切除的结直肠癌肝转移患者经肝动脉灌注亚叶酸钙调节的5-氟尿嘧啶联合静脉注射伊立替康和西妥昔单抗后行肝切除并长期生存的病例报告
Case Rep Oncol Med. 2015;2015:472037. doi: 10.1155/2015/472037. Epub 2015 May 6.
3
Chemotherapy of metastatic colorectal cancer.转移性结直肠癌的化疗
Prescrire Int. 2010 Oct;19(109):219-24.
4
The efficacy and safety of hepatic arterial infusion of oxaliplatin plus intravenous irinotecan, leucovorin and fluorouracil in colorectal cancer with inoperable hepatic metastasis.奥沙利铂肝动脉灌注联合静脉注射伊立替康、亚叶酸钙和氟尿嘧啶治疗不可切除肝转移结直肠癌的疗效与安全性
J Chemother. 2016 Jun;28(3):235-41. doi: 10.1179/1973947815Y.0000000042.
5
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial. upfront FOLFOXIRI 联合贝伐珠单抗和进展后再引入与 mFOLFOX6 联合贝伐珠单抗后序贯 FOLFIRI 联合贝伐珠单抗治疗转移性结直肠癌患者(TRIBE2):一项多中心、开放标签、3 期、随机、对照临床试验。
Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9.
6
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study.西妥昔单抗联合伊立替康/5-氟尿嘧啶/亚叶酸钙(FOLFIRI)用于转移性结直肠癌的初始治疗:一项多中心两部分的I/II期研究。
BMC Cancer. 2009 Apr 14;9:112. doi: 10.1186/1471-2407-9-112.
7
Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.转移性结直肠癌的化疗:氟尿嘧啶加亚叶酸以及伊立替康或奥沙利铂。
Prescrire Int. 2005 Dec;14(80):230-3.
8
Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.西妥昔单抗联合时辰化疗伊立替康、氟尿嘧啶、亚叶酸钙和奥沙利铂治疗结直肠癌肝转移新辅助化疗的研究(POCHER 试验)。
Br J Cancer. 2010 Nov 9;103(10):1542-7. doi: 10.1038/sj.bjc.6605940. Epub 2010 Oct 19.
9
Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.一名结直肠癌患者每2周接受CPT-11治疗,并对5-氟尿嘧啶、亚叶酸钙和奥沙利铂进行4天的时辰调制输注,之后肝脏巨大转移瘤出现显著肿瘤反应。
Anticancer Drugs. 2000 Apr;11(4):263-8. doi: 10.1097/00001813-200004000-00006.
10
Effective chemotherapy and targeted therapy supplemented with stereotactic radiotherapy of a patient with metastatic colon cancer following renal transplantation: a case report.肾移植术后转移性结肠癌患者的有效化疗、靶向治疗联合立体定向放射治疗:一例报告
J Med Case Rep. 2021 Mar 20;15(1):125. doi: 10.1186/s13256-021-02702-y.

引用本文的文献

1
A Case Report of Long-Term Survival following Hepatic Arterial Infusion of L-Folinic Acid Modulated 5-Fluorouracil Combined with Intravenous Irinotecan and Cetuximab Followed by Hepatectomy in a Patient with Initially Unresectable Colorectal Liver Metastases.一例初始不可切除的结直肠癌肝转移患者经肝动脉灌注亚叶酸钙调节的5-氟尿嘧啶联合静脉注射伊立替康和西妥昔单抗后行肝切除并长期生存的病例报告
Case Rep Oncol Med. 2015;2015:472037. doi: 10.1155/2015/472037. Epub 2015 May 6.

本文引用的文献

1
Role of adjuvant therapy after resection of colorectal cancer liver metastases.结直肠癌肝转移术后辅助治疗的作用。
J Clin Oncol. 2010 May 1;28(13):2300-9. doi: 10.1200/JCO.2009.26.9340. Epub 2010 Apr 5.
2
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.氟尿嘧啶肝动脉灌注(HAI)与全身化疗(SCT)治疗不可切除的结直肠癌肝转移
Cochrane Database Syst Rev. 2009 Jul 8(3):CD007823. doi: 10.1002/14651858.CD007823.pub2.
3
Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.西妥昔单抗与化疗联合作为转移性结直肠癌的初始治疗方案
N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
4
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure?初始不可切除的结直肠癌肝转移患者:有治愈的可能吗?
J Clin Oncol. 2009 Apr 10;27(11):1829-35. doi: 10.1200/JCO.2008.19.9273. Epub 2009 Mar 9.
5
Cetuximab with hepatic arterial infusion of chemotherapy for the treatment of colorectal cancer liver metastases.西妥昔单抗联合肝动脉灌注化疗治疗结直肠癌肝转移
Anticancer Res. 2008 Jul-Aug;28(4C):2459-67.
6
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.贝伐单抗联合奥沙利铂为基础的化疗作为转移性结直肠癌的一线治疗:一项随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
7
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.FOLFOX4围手术期化疗联合手术与单纯手术治疗可切除的结直肠癌肝转移(欧洲癌症研究与治疗组织(EORTC)国际协作组试验40983):一项随机对照试验
Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9.
8
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?结直肠癌不可切除肝转移灶肝动脉灌注的Meta分析:一个时代的终结?
J Clin Oncol. 2007 Dec 10;25(35):5649-54. doi: 10.1200/JCO.2007.12.1764.
9
Actual 10-year survival after resection of colorectal liver metastases defines cure.结直肠癌肝转移切除术后的实际10年生存率决定是否治愈。
J Clin Oncol. 2007 Oct 10;25(29):4575-80. doi: 10.1200/JCO.2007.11.0833.
10
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study.1995 - 1999年确诊的欧洲成年患者中八大主要癌症及所有癌症合并的生存率:EUROCARE - 4研究结果。
Lancet Oncol. 2007 Sep;8(9):773-83. doi: 10.1016/S1470-2045(07)70245-0.